Buy Semax – Premium UK Nootropic Research Peptide

Product Overview

If you are looking to research Semax, Cocer Peptides supplies a high-purity, research-grade version of this synthetic heptapeptide. It is an analogue of the adrenocorticotropin fragment (4–10), with the sequence Met-Glu-His-Phe-Pro-Gly-Pro, as catalogued in the NIH PubChem database. Unlike its parent hormone, this peptide is completely devoid of hormonal activity, making it a valuable tool for investigating cognitive and neuroprotective mechanisms without endocrine interference.

Researchers sourcing Semax peptide typically do so because of its well-documented effects on brain-derived neurotrophic factor (BDNF) signalling. A single application (50 μg/kg) has been shown to produce a maximal 1.4-fold increase in BDNF protein levels in the rat hippocampus, alongside a 1.6-fold increase in trkB tyrosine phosphorylation, according to research indexed in the NIH PubMed database. These findings suggest that it affects cognitive brain functions by modulating the expression and activation of the hippocampal BDNF/trkB system.

Important Notice: This product is supplied strictly for laboratory research use only and is not intended for human consumption. Semax is not approved by the MHRA as a medicine in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has warned that products marketed for “research” may still be considered medicinal products if their intended use is for human consumption. The UK Government has taken enforcement action against sellers marketing unlicensed peptide products for human use.

Product Specifications

Mechanism of Action

BDNF/trkB Signalling Pathway

The primary mechanism attributed to Semax is its modulation of the BDNF/trkB signalling system. Research published in ScienceDirect demonstrated that a single application produced a 3-fold increase in exon III BDNF mRNA levels and a 2-fold increase in trkB mRNA levels in the rat hippocampus. Treated animals showed a distinct increase in the number of conditioned avoidance reactions, suggesting enhanced learning and memory processes. Related neurotrophic signalling data is also archived in the NIH PMC database.

Neuroprotective Activity

This peptide exerts marked neuroprotective activities following intranasal application. Research has explored its potential in conditions characterised by disturbed dopamine and BDNF function. A paper published in ScienceDirect proposed that it may have therapeutic potential in attention-deficit hyperactivity disorder (ADHD) because it can augment the effects of psychostimulants on central dopamine release and stimulate central BDNF synthesis. The same paper suggested that increased BDNF activity may be of interest for further exploration in Rett syndrome models.

Cognitive Enhancement Research

Studies have investigated Semax for its effects on selective attention and memory. Evidence from animal studies revealed that it can improve selective attention and modulate brain development. These findings have driven interest in the peptide as a research tool for studying cognitive enhancement pathways. Similar nootropic peptide research is discussed in Frontiers in Neuroscience.

Research Applications

Neurotrophic Factor Research

Semax is widely used in laboratory settings to investigate neurotrophic factor regulation. Its ability to rapidly induce gene- and region-specific changes in neurotrophin gene expression in normal rat brain makes it a valuable compound for BDNF-related research. Additional neurotrophic data is available through Nature.

Cognitive Function Studies

Researchers investigating learning and memory mechanisms frequently utilise this peptide in animal models. Its effects on conditioned avoidance reactions and selective attention provide measurable endpoints for cognitive research. Related behavioural pharmacology methods are documented in The BMJ.

Neurodevelopmental Disorder Research

The potential therapeutic effect of Semax in Rett syndrome and ADHD has been proposed based on its BDNF-enhancing activity. These hypotheses remain areas of active preclinical investigation. Related rare disease research is indexed by the NIH Genetic and Rare Diseases Information Center.

Quality and Purity

Every batch of Cocer Peptides Semax undergoes rigorous quality control:

• ≥99% purity verified by HPLC

• Molecular weight confirmed by mass spectrometry

• Batch number matching the vial label

• Certificate of Analysis (COA) available on request

According to guidance from the JMW Solicitors, research chemical suppliers must be cautious about marketing products in ways that imply human use. The substance of what is promoted matters more than the label attached to it. Analytical standards for peptide characterisation are published by the National Institute for Biological Standards and Control (NIBSC). For researchers purchasing Semax, verifying COA documentation and supplier credentials is essential.

Frequently Asked Questions

What is Semax?

Semax is a synthetic heptapeptide analogue of the adrenocorticotropin fragment (4–10), with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is studied for its effects on BDNF signalling and cognitive function, as documented in the NIH PubChem database.

Where can I buy Semax in the UK?

Cocer Peptides supplies research-grade Semax with third-party COA documentation for laboratory applications. All products are shipped discreetly within the UK.

Is Semax legal in the UK?

This peptide is not a controlled substance under the UK Misuse of Drugs Act 1971 and is typically sold as a research peptide. It is not approved by the MHRA as a medicine, as outlined by GOV.UK.

What purity level can I expect?

Our Semax is provided at ≥99% purity, verified by HPLC with third-party testing.

How should Semax be stored?

Store lyophilized powder at -20°C for long-term stability. Reconstituted material should be stored at 2–8°C and used promptly following standard laboratory protocols.

Is this product suitable for human use?

No. This product is supplied strictly for research purposes only and is not intended for human consumption. The Medicines and Healthcare products Regulatory Agency (MHRA) advises that medicines should only be obtained from regulated sources.

Conclusion

Semax represents a well-characterised research tool for investigating BDNF/trkB signalling, neuroprotective mechanisms, and cognitive function pathways. Its documented effects on hippocampal neurotrophic factor expression provide a strong foundation for laboratory research, as published in ScienceDirect. For scientists seeking to source Semax peptide for research purposes, Cocer Peptides offers high-purity material with complete analytical documentation and batch-specific COA support.

Ready to Advance Your Research?

Order premium Semax for your laboratory today.

Buy Semax Now | Contact Our Research Team